Scarica l'app Stockscreener
17.24
0.06%
-0.01
Pre-mercato:
17.24
Sanara Medtech Inc Borsa (SMTI) Ultime notizie
Sanara MedTech (NASDAQ:SMTI) Lowered to Hold Rating by Wall Street Zen - Defense World
Reviewing Sanara MedTech (NASDAQ:SMTI) & ICU Medical (NASDAQ:ICUI) - Defense World
Q4 EPS Estimates for Sanara MedTech Decreased by Analyst - MarketBeat
Recap Report: Is Sanara MedTech Inc undervalued by DCF analysis2026 Top Decliners & Stepwise Swing Trade Plans - baoquankhu1.vn
Aug Chart Watch: Is Sanara MedTech Inc showing insider buying2026 Technicals & Reliable Entry Point Alerts - baoquankhu1.vn
(SMTI) Volatility Zones as Tactical Triggers - Stock Traders Daily
Sanara MedTech Q4 2025 Earnings Call Transcript - MarketBeat
Sanara MedTech Earnings Call Signals Growth Momentum - The Globe and Mail
Sanara MedTech shares rise more than 3% despite fourth-quarter earnings miss - MSN
Sanara MedTech (NASDAQ:SMTI) Upgraded by Wall Street Zen to Buy Rating - MarketBeat
Sanara MedTech Inc. (NASDAQ:SMTI) Q4 2025 Earnings Call Transcript - Insider Monkey
Retail Trends: Can Sanara MedTech Inc maintain sales growth2026 Technical Patterns & AI Forecasted Entry and Exit Points - baoquankhu1.vn
Sanara MedTech Hits 52-Week Low of $17.54 Amidst Market Struggles - Markets Mojo
Sanara MedTech Inc. Q4 2025 Earnings Call Summary - finance.yahoo.com
Sanara MedTech Reports Strong 2025 Financial Results With 19% Revenue Growth, Reaffirms 2026 Guidance - Minichart
Sanara MedTech (SMTI) to Release Quarterly Earnings on Wednesday - MarketBeat
Sanara MedTech Inc. 2025 Business Overview: Surgical Product Focus, Innovation Strategy, and Regulatory Compliance - Minichart
Sanara MedTech Inc. (SMTI) Q4 earnings miss estimates - MSN
Sanara MedTech Inc (SMTI) Q4 2025 Earnings Call Highlights: Record Revenue and Strategic Growth ... By GuruFocus - ca.investing.com
Sanara MedTech (NASDAQ: SMTI) ends THP unit, doubles down on surgery - Stock Titan
Sanara MedTech Inc (SMTI) Q4 2025 Earnings Call Highlights: Reco - GuruFocus
Sanara MedTech stock rises over 3% despite fourth quarter miss By Investing.com - Investing.com India
Targets Report: Can Sanara MedTech Inc deliver consistent dividends2026 Market Sentiment & Fast Entry High Yield Stock Tips - baoquankhu1.vn
Sanara MedTech Inc. (SMTI) Q4 and Full Year 2025 Earnings: Revenue Hits $103.1 Million With 19% Growth - Bayelsa Watch
Earnings Call Summary | Sanara MedTech(SMTI.US) Q4 2025 Earnings Conference - 富途牛牛
Sanara Medtech earnings missed by $0.52, revenue fell short of estimates - Investing.com Canada
Earnings call transcript: Sanara MedTech Q4 2025 misses EPS forecast, stock drops - in.investing.com
Sanara MedTech Inc. (SMTI) Q4 Earnings: Misses on EPS, Revenue Recap - AlphaStreet
Sanara MedTech Q4 Earnings Call Highlights - Yahoo Finance
Sanara MedTech Inc. (SMTI) Misses Q4 EPS Estimates by 215.9% - AlphaStreet
Sanara MedTech Inc. (SMTI) Q4 Earnings Miss Estimates - Yahoo Finance
Sanara Medtech Inc. Reaffirms Revenue Guidance for the Full Year Ending December 31, 2026 - MarketScreener
Sanara MedTech stock rises over 3% despite fourth quarter miss - Investing.com
Sanara MedTech Inc. Reports Fourth Quarter (Unaudited) and Full Year 2025 Financial Results; Reaffirmed Full Year 2026 Financial Guidance - The Manila Times
Sanara MedTech reports FY2025 revenue $103.1M, Q4 revenue $27.5M and Adjusted EBITDA $17.0M - TradingView
Sanara MedTech posts higher Q4 revenue, reaffirms guidance - TradingView
Sanara MedTech Inc. Reports Fourth Quarter (Unaudited) and - GlobeNewswire
Sanara MedTech Inc. (SMTI) Q4 Results Fall Short of Projections - Bitget
Sanara MedTech (SMTI) CEO receives 25,430-share restricted stock grant vesting through 2029 - Stock Titan
Sanara MedTech (SMTI) grants restricted stock to controller vesting through 2029 - Stock Titan
Sanara MedTech (SMTI) awards COO 13,956 restricted shares - stocktitan.net
Sanara MedTech (SMTI) CFO awarded 12,687 restricted shares vesting 2027-2029 - stocktitan.net
What To Expect From Sanara MedTech Inc (SMTI) Q4 2025 Earnings - GuruFocus
Can Sanara MedTech Inc grow without external fundingDay Trade & AI Enhanced Market Trend Forecasts - baoquankhu1.vn
Price-Driven Insight from (SMTI) for Rule-Based Strategy - Stock Traders Daily
Is Sanara MedTech Inc undervalued by DCF analysisWeekly Trend Recap & Weekly Momentum Stock Picks - baoquankhu1.vn
Sanara MedTech (NASDAQ:SMTI) Trading Up 0.8%Here's What Happened - MarketBeat
Aug Selloffs: Can Sanara MedTech Inc maintain sales growth2026 Earnings Surprises & High Accuracy Trade Alerts - baoquankhu1.vn
Sanara MedTech Inc. Announces Publication of Peer-Reviewed Study Evaluating the Economic and Clinical Value of CellerateRX® Surgical Powder in the Management of Spine Surgery Wounds - Orthopedics This Week
Sanara MedTech (SMTI) upgraded to strong buy: Here's what you should know - MSN
Sanara MedTech study shows cost savings with CellerateRX powder By Investing.com - Investing.com India
Sanara MedTech Inc. Announces Publication of Peer-Reviewed - GlobeNewswire
Sanara MedTech study shows cost savings with CellerateRX powder - Investing.com
1.21%
0.07%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):